Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 9121 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#9121, RRID:AB_331648
- Product name
- Phospho-MEK1/2 (Ser217/221) Antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse, Rat, Simian, Yeast
- Host
- Rabbit
- Storage
- -20°C
Submitted references Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells.
Hypertonicity-induced aquaporin-1 (AQP1) expression is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene.
Disruption of the 14-3-3 binding site within the B-Raf kinase domain uncouples catalytic activity from PC12 cell differentiation.
Rap1A protein interferes with various MAP kinase activating pathways in skeletal myogenic cells.
Requirement for ERK activation in cisplatin-induced apoptosis.
Piatelli MJ, Wardle C, Blois J, Doughty C, Schram BR, Rothstein TL, Chiles TC
Journal of immunology (Baltimore, Md. : 1950) 2004 Mar 1;172(5):2753-62
Journal of immunology (Baltimore, Md. : 1950) 2004 Mar 1;172(5):2753-62
Hypertonicity-induced aquaporin-1 (AQP1) expression is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene.
Umenishi F, Schrier RW
The Journal of biological chemistry 2003 May 2;278(18):15765-70
The Journal of biological chemistry 2003 May 2;278(18):15765-70
Disruption of the 14-3-3 binding site within the B-Raf kinase domain uncouples catalytic activity from PC12 cell differentiation.
MacNicol MC, Muslin AJ, MacNicol AM
The Journal of biological chemistry 2000 Feb 11;275(6):3803-9
The Journal of biological chemistry 2000 Feb 11;275(6):3803-9
Rap1A protein interferes with various MAP kinase activating pathways in skeletal myogenic cells.
Pizon V, Baldacci G
Oncogene 2000 Dec 7;19(52):6074-81
Oncogene 2000 Dec 7;19(52):6074-81
Requirement for ERK activation in cisplatin-induced apoptosis.
Wang X, Martindale JL, Holbrook NJ
The Journal of biological chemistry 2000 Dec 15;275(50):39435-43
The Journal of biological chemistry 2000 Dec 15;275(50):39435-43
No comments: Submit comment
No validations: Submit validation data